PET/CT in Gynecological Cancers
This book is a pocket guide to the science and practice of PET/CT imaging of gynecological malignancies. The scientific principles of PET/CT, the radiopharmaceuticals used in the context of gynecological cancers, the role of PET/CT in these patients, the
- PDF / 8,724,427 Bytes
- 131 Pages / 439.43 x 666.14 pts Page_size
- 69 Downloads / 244 Views
a Barwick Andrea Rockall Editors
PET/CT in Gynecological Cancers
Clinicians’ Guides to Radionuclide Hybrid Imaging Series editors: Jamshed B. Bomanji London, UK Gopinath Gnanasegaran London, UK Stefano Fanti Bologna, Italy Homer A. Macapinlac Houston, Texas, USA
More information about this series at http://www.springer.com/series/13803
Tara Barwick • Andrea Rockall Editors
PET/CT in Gynecological Cancers
Editors Tara Barwick Imperial College Healthcare NHS Trust London, UK
Andrea Rockall Imperial College Healthcare NHS Trust London, UK
Department of Surgery and Cancer Imperial College London, UK
Department of Surgery and Cancer Imperial College London, UK
ISSN 2367-2439 ISSN 2367-2447 (electronic) Clinicians’ Guides to Radionuclide Hybrid Imaging - PET/CT ISBN 978-3-319-29247-2 ISBN 978-3-319-29249-6 (eBook) DOI 10.1007/978-3-319-29249-6 Library of Congress Control Number: 2016940198 © Springer International Publishing Switzerland 2016 This work is subject to copyright. All rights are reserved by the Publisher, whether the whole or part of the material is concerned, specifically the rights of translation, reprinting, reuse of illustrations, recitation, broadcasting, reproduction on microfilms or in any other physical way, and transmission or information storage and retrieval, electronic adaptation, computer software, or by similar or dissimilar methodology now known or hereafter developed. The use of general descriptive names, registered names, trademarks, service marks, etc. in this publication does not imply, even in the absence of a specific statement, that such names are exempt from the relevant protective laws and regulations and therefore free for general use. The publisher, the authors and the editors are safe to assume that the advice and information in this book are believed to be true and accurate at the date of publication. Neither the publisher nor the authors or the editors give a warranty, express or implied, with respect to the material contained herein or for any errors or omissions that may have been made. Printed on acid-free paper This Springer imprint is published by Springer Nature The registered company is Springer International Publishing AG Switzerland
Foreword
Clear and concise clinical indications for PET/CT in the management of the oncology patient are presented in this series of 15 separate Booklets. The impact on better staging, tailored management and specific treatment of the patient with cancer has been achieved with the advent of this multimodality imaging technology. Early and accurate diagnosis will always pay, and clear information can be gathered with PET/CT on treatment responses. Prognostic information is gathered and can forward guide additional therapeutic options. It is a fortunate coincidence that PET/CT was able to derive great benefit from radionuclide-labelled probes, which deliver good and often excellent target to nontarget signals. Whilst labelled glucose remains the cornerstone for the clinical benefit achieved, a number of recent probes are definitel
Data Loading...
